Works matching IS 0008543X AND DT 2022 AND VI 128 AND IP 17


Results: 19
    2
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 17, p. 3185, doi. 10.1002/cncr.34366
    By:
    • Hollebecque, Antoine;
    • Salvagni, Stefania;
    • Plummer, Ruth;
    • Niccoli, Patricia;
    • Capdevila, Jaume;
    • Curigliano, Giuseppe;
    • Moreno, Victor;
    • de Braud, Filippo;
    • de Villambrosia, Sonia Gonzalez;
    • Martin‐Romano, Patricia;
    • Baudin, Eric;
    • Arias, Marina;
    • de Alvaro, Juan;
    • Parra‐Palau, Josep L.;
    • Sánchez‐Pérez, Tania;
    • Aronchik, Ida;
    • Filvaroff, Ellen H.;
    • Lamba, Manisha;
    • Nikolova, Zariana;
    • de Bono, Johann S.
    Publication type:
    Article
    15
    16
    17
    18
    19

    Issue Information.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 17, p. 3135, doi. 10.1002/cncr.33021
    Publication type:
    Article